Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 36,094 | 40,397 | 38,010 | -85,403 | -72,710 |
| Depreciation Amortization | 2,242 | 2,289 | 2,054 | 4,811 | 3,921 |
| Accounts receivable | -431 | 1,482 | -7,393 | 32,626 | 32,773 |
| Accounts payable and accrued liabilities | -4,049 | -3,066 | -2,983 | 687 | -1,537 |
| Other Working Capital | -102,761 | -94,884 | -82,113 | -30,959 | -8,554 |
| Other Operating Activity | 23,662 | 18,326 | 24,287 | 9,521 | 1,861 |
| Operating Cash Flow | $-45,243 | $-35,456 | $-28,138 | $-68,717 | $-44,246 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,315 | 11,780 | 17,199 | 8,870 | 5,404 |
| PPE Investments | 393 | 349 | N/A | -246 | -156 |
| Investing Cash Flow | $9,708 | $12,129 | $17,199 | $8,624 | $5,248 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -250 | -250 | -250 | -892 | -657 |
| Common Stock Issued | 16,352 | 1 | N/A | 9,578 | 60,274 |
| Other Financing Activity | -1 | 15,303 | 0 | 50,596 | -7 |
| Financing Cash Flow | $16,101 | $15,054 | $-250 | $59,282 | $59,610 |
| Beginning Cash Position | 25,176 | 25,176 | 25,176 | 25,987 | 25,987 |
| End Cash Position | 5,742 | 16,903 | 13,987 | 25,176 | 46,599 |
| Net Cash Flow | $-19,434 | $-8,273 | $-11,189 | $-811 | $20,612 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,243 | -35,456 | -28,138 | -68,717 | -44,246 |
| Capital Expenditure | N/A | N/A | N/A | -246 | -156 |
| Free Cash Flow | -45,243 | -35,456 | -28,138 | -68,963 | -44,402 |